Showing results (11-20 of 261) with videos related to
Sort By:
Pageof 27
International Journal of Clinical Practice|May 23, 2002
The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesisR BullockCiba Foundation Symposium|January 1, 1979
The place of histochemical techniques in toxicology, pharmacology and pathologyG R BullockCurrent Pharmaceutical Design|September 20, 2001
Medical treatment and neuroprotection in traumatic brain injuryT Clausen, R BullockJournal of Neurotrauma|June 1, 1995
The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA1021 on ischemic brain damage caused by acute subdural hematoma in the ratE Tsuchida, R BullockJournal of Neurotrauma|May 1, 1992
The role of glutamate antagonists for the treatment of CNS injuryR Bullock, H FujisawaEuropean Psychiatry : the Journal of the Association of European Psychiatrists|April 26, 2002
Risperidone in the treatment of psychoses in the elderly: a case report seriesR Bullock, S LibrettoCurrent Medical Research and Opinion|September 21, 2002
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case seriesR Bullock, A CameronJournal of Neurosurgery|October 1, 1996
Effect of the novel high-affinity glycine-site N-methyl-D-aspartate antagonist ACEA-1021 on 125I-MK-801 binding after subdural hematoma in the rat: an in vivo autoradiographic studyX Di, R BullockInternational Journal of Geriatric Psychiatry|November 11, 1999
Validation of a 6 item cognitive impairment test with a view to primary care usageP Brooke, R BullockPageof 27